Physician profile
Michael J Reed
NPI 1417183351
$3,167.55
in general payments reported to CMS, 2019-2025
26 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $129 · 2021: $246 · 2022: $328 · 2023: $400 · 2024: $696 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,248.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $606.38 | 2021-2024 | Trudi Nav Cable, Acclarent Aera, Acclarent Navwire |
| Integra Lifesciences Corporation | $518.33 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Regeneron Healthcare Solutions, INC. | $326.78 | 2019-2025 | Dupixent |
| Genzyme Corporation | $262.45 | 2019-2025 | |
| Smith+Nephew, INC. | $203.69 | 2019-2025 | Tula, Halo, Coblation |
| Medtronic, INC. | $203.36 | 2025 | Stealthstation S8 Platform |
| Organogenesis INC. | $176.22 | 2023-2025 | Novachor, Affinity, Puraply |
| Stryker Corporation | $118.40 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $101.15 | 2022-2025 | |
| Preceptis Medical, INC. | $95.13 | 2025 | |
| Intersect Ent, INC. | $84.33 | 2020-2022 | |
| Optinose US, INC. | $76.85 | 2019-2024 | |
| Alk-Abello, INC | $55.95 | 2019-2023 | Standardized Mite D. Farinae, Histamine Positive, Timothy, Standardized |
| Itamar Medical INC | $42.22 | 2022 | |
| Phathom Pharmaceuticals, INC. | $38.18 | 2024-2025 | Voquezna |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $35.00 | 2024-2025 | |
| Cochlear Americas | $33.45 | 2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Karl Storz Endoscopy-America | $32.78 | 2019 | |
| Glaxosmithkline, LLC. | $29.94 | 2023-2025 | Nucala |
| Amgen INC. | $22.76 | 2025 | Tezspire |
| Greer Laboratories, INC. | $21.18 | 2025 | Oralair |
| Astrazeneca Pharmaceuticals LP | $19.00 | 2025 | Tezspire |
| Axsome Therapeutics, INC. | $17.83 | 2022 | |
| Paratek Pharmaceuticals, INC. | $17.09 | 2025 | Xhance |
| Avadel Cns Pharmaceuticals, LLC | $14.85 | 2025 | Lumryz |
| Ars Pharmaceuticals Operations, INC. | $14.25 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.